|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/50 | |
| C12N 15/57 | |||
| C07K 19/00 | |||
| C12N 15/62 | |||
| A61K 38/48 | |||
| A61P 35/00 |
| (11) | Number of the document | 3064579 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16163214.6 |
| Date of filing the European patent application | 2009-11-02 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 110218 P | 2008-10-31 | US |
| (72) |
Georgiou, George, US
Stone, Everett, US
|
| (73) |
AERase, Inc.,
901 S. MoPac Expressway Barton Plaza One, Suite 250, Austin, TX 78746,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES OF ENGINEERED HUMAN ARGINASES |
| PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES OF ENGINEERED HUMAN ARGINASES |